No­vo Nordisk paus­es ad cam­paign for obe­si­ty drug We­govy amid un­prece­dent­ed de­mand

No­vo Nordisk is hit­ting the brakes on a na­tion­al ad­ver­tis­ing cam­paign for obe­si­ty drug We­govy.

Af­ter launch­ing a TV com­mer­cial re­gion­al­ly ear­li­er this year, No­vo told End­points News it’s now paus­ing the lo­cal ads and post­pon­ing na­tion­al ad­ver­tis­ing plans in an ef­fort to keep de­mand in check for the pop­u­lar drug, al­so known by its non-pro­pri­etary name semaglu­tide.

“Giv­en the cur­rent sit­u­a­tion, to avoid stim­u­lat­ing fur­ther de­mand for this med­i­cine, we’re paus­ing some key We­govy pro­mo­tion­al ef­forts,” a No­vo Nordisk spokesper­son said via email.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER